Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jaeho Jung
Observed names:
J Jung,
JAEHO JUNG,
Jae-Ho Jung
Institution:
ABL Bio (South Korea)
Observed institutions:
Ministry of Food and Drug Safety,
Pohang University of Science and Technology,
Ochsner Medical Center,
Korea Institute of Radiological and Medical Sciences,
ABL Bio (South Korea),
The Ohio State University
show all 6
ORCID:
0000-0001-6589-0823
Observed ORCID:
0000-0001-6589-0823
OpenAlex ID:
A5101727166
Stress‐Induced Neuroendocrine Modulation of Viral Pathogenesis and Immunitya
1998
·
JOHN F. SHERIDAN
, CATHLEEN DOBBS
, et al.
·
Annals of the New York Academy of Sciences
·
147
Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10
2000
·
Jaeho Jung
, Jongseon Choe
, et al.
·
European Journal of Immunology
·
133
PDF
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation
2022
·
Eunsil Sung
, Minkyung Ko
, et al.
·
Molecular Therapy
·
77
PDF
The Distinct Roles of T Cell-Derived Cytokines and a Novel Follicular Dendritic Cell-Signaling Molecule 8D6 in Germinal Center-B Cell Differentiation
2001
·
Xin Zhang
, Li Li
, et al.
·
The Journal of Immunology
·
67
PDF
Distinct Response of Human B Cell Subpopulations in Recognition of an Innate Immune Signal, CpG DNA
2002
·
Jaeho Jung
, Ae-Kyung Yi
, et al.
·
The Journal of Immunology
·
60
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade
2021
·
Seongju Jeong
, Eunyoung Park
, et al.
·
Journal for ImmunoTherapy of Cancer
·
58
PDF
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8 + tumor-infiltrating lymphocytes
2021
·
Gihoon You
, Yangsoon Lee
, et al.
·
Science Advances
·
57
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
2023
·
Jing Gao
, Zhengyi Wang
, et al.
·
Journal for ImmunoTherapy of Cancer
·
54
PDF
Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK
2001
·
Y Kagami
, J Jung
, et al.
·
Leukemia
·
43
Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2024
·
Seung Hyuck Jeon
, Gihoon You
, et al.
·
Clinical Cancer Research
·
15
Tumor targeting of humanized fragment antibody secreted from transgenic rice cell suspension culture
2008
·
Shin-Young Hong
, Tae-Sup Lee
, et al.
·
Plant Molecular Biology
·
15
Abstract 1633: ABL501, PD-L1 x LAG-3, a bispecific antibody promotes enhanced human T cell activation through targeting simultaneously two immune checkpoint inhibitors, LAG-3 and PD-L1
2021
·
Eunyoung Park
, Hyunejoo Kim
, et al.
·
Cancer Research
·
4
702 TJ-CD4B (ABL111), a Claudin18.2-targeted 4-1BB tumor engager induces potent tumor-dependent immune response without dose-limiting toxicity in preclinical studies
2021
·
Wenqing Jiang
, Zhengyi Wang
, et al.
·
Regular and Young Investigator Award Abstracts
·
3
PDF
Abstract 5644: Claudin 18.2 X 4-1BB bispecific antibody induced potent tumor inhibition through tumor-specific 4-1BB activation
2020
·
Wenqing Jiang
, Lei Fang
, et al.
·
Cancer Research
·
3
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 27–28 April 2017
2017
·
Meenu Wadhwa
, Hye-Na Kang
, et al.
·
Biologicals
·
3
Abstract 6524: A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) shows potent anti-tumor effect through tumor-directed T cell activation
2020
·
Moo Young Song
, Eun-Jung Lee
, et al.
·
Cancer Research
·
2
Cytokine and chemokine gene expression during influenza virus infection, and the effects of restraint stress /
1996
·
Jaeho Jung
·
OhioLink ETD Center (Ohio Library and Information Network)
·
2
PDF
Data from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2024
·
Seung Hyuck Jeon
, Gihoon You
, et al.
·
1
792 Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer
2023
·
Xuejun Liu
, Ke Xu
, et al.
·
Regular and Young Investigator Award Abstracts
·
1
PDF
Abstract 1139: A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) exhibits the optimal efficacy and superior safety profile through tumor-directed 4-1BB agonism
2022
·
Eunjung Lee
, Hyejin Chung
, et al.
·
Cancer Research
·
1
The Effects of Tranilast $^{circled R}$ on the Cellular Proliferation, Collagen Synthesis, and Secretion of TGF-/ $\beta_1$ in Bovine Retinal Pigment Epithelial Cells.
2003
·
Jong Soo Lee
, Young-Gun Shin
, et al.
·
Journal of the Korean Ophthalmological Society
·
1
Supplementary Figures S1-7 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2024
·
Seung Hyuck Jeon
, Gihoon You
, et al.
Supplementary Tables 1-3 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2024
·
Seung Hyuck Jeon
, Gihoon You
, et al.
Data from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2024
·
Seung Hyuck Jeon
, Gihoon You
, et al.
Supplementary Tables 4-7 from Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
2024
·
Seung Hyuck Jeon
, Gihoon You
, et al.
Show more works
View as search
Works count:
35
Citation count:
747
H-index:
11
I10-index:
11
Year
Topic
Type
